Latest Predictions For Vitreomacular Traction Treatment In 2023

Retinal specialists who are considering pharmacological or surgical intervention to resolve vitreomacular traction treatment should consider ocular history when deciding if surgery is the right option. Studies found that patients with inner retinal involvement were more likely to resolve than patients who had inner and outer retinal involvement.

The estimated range for the prevalence of vitreomacular traction associated with ocular disease is between 0.35% and 1.5% of the global population. This is a large disease burden with a large treatment demand. The vitreotraction on the macular is caused by anomalous and incomplete vitreous detachment, associated with many other conditions, including age-related macular degeneration, retinal vein occlusion, and diabetic macular edema.

Vitreomacular traction causes the retina to change in structure, which results in a loss of central vision. Spontaneous resolution is not unheard of, depending on how long the patient has experienced symptoms. Studies focusing on the factors associated with spontaneous resolution have been in high demand as of late, identifying predictive factors to help specialists decide when vitreomacular traction treatment is needed.

The study focused on sixty-one vitreomacular traction patients, based on optical coherence tomography results, excluding patients who had previous surgeries to treat the condition. The VMT was classified by inner only and inner and outer retinal involvement. The patients with inner retinal distortion proved that the vitreomacular traction caused abnormal retinal architecture including the nuclear layer, while those with inner and outer involvement saw the outer retinal architecture being involved.

Ray Man, the PA for Mahi Muqit, a leading vitreomacular traction surgeon in London, said “The patients were observed over one year with thirty-five percent of the patients experiencing a resolution within that period, while sixty-five percent did not. The patients who experienced spontaneous resolution were more likely to have inner retinal distortion only. It was also noted that patients with inner and outer retinal involvement were less likely to experience spontaneous resolution, resulting in the need for treatment.”

Mahi Muqit is a leading retina surgeon who operates from a private eye hospital in London, backed by years of experience and along with numerous accreditations. He has written numerous papers on vitreomacular traction treatments and is a leading choice for patients struggling with this eye condition.

About Us:

Mahi Muqit is a leading consultant ophthalmologist, cataract, and vitreoretinal surgeon at two private clinics in London, United Kingdom. He provides patients with superior service and support with a range of surgical procedures to meet their eyesight requirements. He has built up a solid reputation for his eye services in the London area as an expert eye doctor and surgeon offering surgical retina, medical retina, and complex cataract surgery. He also offers surgery to patients suffering from diabetic retinopathy. Mahi Muqit is a member of the Royal College of Ophthalmologists, a member of the British and Eire Association of Vitreoretinal Surgeons, and the UK and Ireland Society of Cataract and Refractive Surgeons. To find out more, visit
https://www.retinasurgeon.uk.com/.